Fauci joins Georgetown faculty
April 18th, 2024
This summer, infectious diseases expert and advisor to seven presidents Anthony Fauci, M.D., joined the Georgetown faculty as a Distinguished University Professor, the university’s highest professional honor that recognizes extraordinary achievement in scholarship, teaching, and service.…
The curious brain
April 18th, 2024
From the time he was a young boy, fascinated with dinosaurs and his rock collection, Zac Colon (G’21) always felt drawn to the sciences. He liked understanding how organisms and systems worked—at one point even informing his parents he wanted to autopsy a dead squirrel.…
Save the Date: 3rd Annual Georgetown University Center for Healthy Aging Symposium: July 10, 2024
March 25th, 2024
The Georgetown Center for Healthy Aging, the Aging and Alzheimer’s Research Training Program, the Georgetown Aging & Health Program, and the Georgetown Lombardi Institute for Cancer and Aging…
Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors
September 30th, 2022
Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors, published today in the Journal of Clinical Oncology, adds important evidence to that potential link. …
Research Reveals How Aging Cells Can Be an Underlying Cause of Kidney Damage
December 8th, 2021
A study in mice by researchers at Georgetown Lombardi Comprehensive Cancer Center has found that stress and tissue damage initiated by angiotensin II, a molecule that is known to increase blood pressure and stiffening in the linings of blood vessels, leads to cellular senescence, a process by which a cell ages and permanently stops dividing but does not die. Importantly, when the researchers eliminated senescent cells from the mice, tissues returned to a normal state in spite of a continued infusion of angiotensin II.…
Reducing your risk of cognitive disease: A $12M research study, 60 years in the making
December 6th, 2021
A McCourt researcher has dedicated her career to aging research and a decades-old study, revealing a non-medical intervention that proves resilient against dementia.…
Trial Stopped Early: Giving Immunotherapy Before Targeted Rx Improves Survival in Advanced Melanoma
November 15th, 2021
More people with advanced melanoma survive for two years or more when they receive a combination of two immunotherapy drugs given before a combination of two targeted therapies, if needed, compared to people who start treatment with targeted therapies. The finding comes from a clinical trial that was stopped early because definitive results became apparent sooner than expected. It provides strong evidence for how best to treat patients with melanoma that has a specific mutation: Immunotherapy is the better initial approach even for people whose tumors have a mutation that could be treated by targeted therapies.…
Vascular Defects Appear to Underlie the Progression of Parkinson’s Disease
November 12th, 2021
In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson’s disease. The finding could help explain an earlier outcome of the same study, in which the drug nilotinib was able to halt motor and nonmotor (cognition and quality of life) decline in the long term.…
Adult Gerontology Acute Care Nurse Practitioner Program Extends Values-Based Education Across United States
October 20th, 2021
When Dr. Kelly Thompson-Brazill first joined Georgetown’s faculty five years ago, she attended a simulation exercise and debriefing session for students in the Adult Gerontology Acute Care Nurse Practitioner Program at the School of Nursing & Health Studies.…
Critical Period After Stroke Study (CPASS): A Phase II Clinical Trial Testing an Optimal Time for Motor Recovery After Stroke in Humans
September 20th, 2021
A phase II randomized clinical trial found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should begin 60 to 90 days after the event. The study, conducted by Georgetown University and MedStar National Rehabilitation Network (NRH) researchers, was published September 20, 2021, in PNAS (Critical Period After Stroke Study (CPASS): A Phase II Clinical Trial Testing an Optimal Time for Motor Recovery After Stroke in Humans).…
Insights Into How a Stroke Affects Reading Could Help With Rehabilitation
August 29th, 2021
Georgetown University researchers, looking at the ability of people to sound out words after a stroke, found that knowing which region of the brain was impacted by the stroke could have important implications for helping target rehabilitation efforts.…
Key Mental Abilities Can Actually Improve During Aging
August 19th, 2021
It’s long been believed that advancing age leads to broad declines in our mental abilities. Now, new research from Georgetown University Medical Center offers surprisingly good news by countering this view.…
Renowned Georgetown Cancer and Aging Researcher Receives Top Honor in Her Field
March 28th, 2021
The American Society of Preventive Oncology selected Jeanne Mandelblatt, MD, MPH, to receive the 2020 Joseph F. Fraumeni Jr. Distinguished Achievement Award, its top honor.…
